1[1]Evans AE. Mytomycin. Cancer Chemotherre P,1961,14:1 ～9
2[2]Sullivan MP, Sutow, Taylor G. phenylaaninemu stardasa treatment for metastatic osteogenic sarcoma in children. JPediate, 1963,63:227 ～237.
3[3]Cores EP, Holland JE,Wang JJ, Doxorubincin in disseminated osteosarcoma. JAMA, 1972. 221:1132 - 1138.
4[4]Jaffe N, Recent advance in the chemotherapy of metastatic osteogenic sarcoma. Cancer, 1972,30:1627 - 1631.
5[5]Rosen G, Tan C, Anmaneechai A, et al. The rationale for multiple drug chemotherapy in the treatment of osteosarcoma. Cancer, 1975,35 (supple) :936 ～ 945.
6[6]Uehida A, Myoui A, Are ki N, et al. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer, 1997,79:411 - 415.
7[7]Juliano RI, Ling V. A surface glycoprotein moderating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta,1976,455:152.
8[8]Park YB, Kim HS, The co-expression of p53 protein and p-glycoprotein is correlated to a poor progress in osteosarcoma. Int orchop.2001,24:307 - 310.
9[9]Burak A,Gibassier J, Raoul M. Effect of S9788 on the efficiency of doxorubincin in vivo and in vitro in medullary thyroidcarcinoma xenograft. Anti - Cancer Drugs, 1996,7:321.
10[10]Stein TL. Walther W. wunerlich V. Point matstions in the mdr1 promoter of human osteosarcomes are associated with in vitro responsiven. Eur J Cancer. 1994:30A: 1541 - 1545.
4Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy [ J ]. Cancer, 2002,49 (6) : 1221-1230.
5Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity [ J ]. N Engl J Med, 2005,314 (25) : 1600- 1606.
6Jaffe N. Recent advances in the chemotherapy of metas tatic osteogenic sarcoma [ J]. Clin Orthop Relat Res, 2000, (270) :4-7.
7Marina N, Gebhardt M,Teot L, et al. Biology and therapeutic advances for pediatric osteo-sarcoma [J]. Oncologist,2004,9 (4):422-441.
8Bielack SS,Machatschek JN, Flege S, et al. Delaying surgery with chemotherapy for osteo-sarcoma of the extremities[ J ]. Expert Opin Pharmacother, 2004,5 ( 6 ) : 1243- 1256.
9Longhi A,Errani C, De Paolis M, et al. Primary bone osteosarcoma in the pediatric age state of the art[ J ]. Cancer Treat Rev ,2006,32 (6) :4-23436.
10Antman KH,Growley J, Balcerzak SP et ah An intergroup phase III randomized study of doxorubicin and dacarba- zine with or without ifosfamide and mesna in advanced soft2tissue and bone sarcoma [ J ]. J Clin Oncol, 2003,11 (6) : 1276-1285.
